NCT02318537View on ClinicalTrials.gov

Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Lennox-Gastaut Syndrome

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 30, 2017

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Lennox-Gastaut Syndrome
Interventions
DRUG

Cannabidiol Oral Solution

An oral solution containing pharmaceutical grade cannabidiol (nonplant-based).

DRUG

Placebo Solution

A matching oral solution containing no cannabidiol.

Sponsors
All Listed Sponsors
lead

INSYS Therapeutics Inc

INDUSTRY